There was missing disclosure information in the article by Loss and colleagues (1), published in the April 15, 2016, issue of the Journal. The authors omitted to mention that Erika von Mutius should have been listed as an inventor on the following patents:
Publication number EP 1411977: Composition containing bacterial antigens used for the prophylaxis and the treatment of allergic diseases
Publication number EP1637147: Stable dust extract for allergy protection
Publication number EP 1964570: Pharmaceutical compound to protect against allergies and inflammatory diseases
In addition, Dr. von Mutius should have been listed as an inventor on the following patent, for which she has received royalties:
Publication number EP2361632: Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune disorders
This information has been incorporated in the ICMJE Disclosure of Potential Conflicts of Interest form accessible from the article’s online supplements tab.
|1.||Loss GJ, Depner M, Hose AJ, Genuneit J, Karvonen AM, Hyvärinen A, Roduit C, Kabesch M, Lauener R, Pfefferle PI, Pekkanen J, Dalphin J-C, Riedler J, Braun-Fahrländer C, von Mutius E, Ege MJ; PASTURE (Protection against Allergy Study in Rural Environments) Study Group. The early development of wheeze. Environmental determinants and genetic susceptibility at 17q21. Am J Respir Crit Care Med 2016;193:889–897.|